BCAB
Price:
$3.655
Market Cap:
$4.61M
BioAtla Inc. is a biopharmaceutical firm currently in the clinical development phase, focused on creating highly specific and selective antibody-derived treatments designed to combat solid tumor cancers. The company's primary experimental therapeutic, BA3011, is a conditionally active biologic antibody-drug conjugate (CAB ADC) being investigated for its potential against soft tissue and bone sarcoma, non-small cell lung cancer (NSCLC), and ovarian cancer. Additionally, BioAtla is advancing BA3021, another CAB ADC, for a variety of solid malignancies such as NSCLC, melanoma, and ovarian cancer. A third candidate, BA3071, is a conditionally active anti-cytotoxic T-lymphocyte-associated antigen...[Read more]
Industry
Biotechnology
IPO Date
2020-12-16
Stock Exchange
NASDAQ
Ticker
BCAB
According to BioAtla, Inc.’s latest financial reports and current stock price. The company's current ROE is 166.67%. This represents a change of 223.17% compared to the average of 51.57% of the last 4 quarters.
The mean historical ROE of BioAtla, Inc. over the last ten years is -58.10%. The current 166.67% ROE has changed -386.87% with respect to the historical average. Over the past ten years (40 quarters), BCAB's ROE was at its highest in in the June 2025 quarter at 111.74%. The ROE was at its lowest in in the March 2025 quarter at -2803.29%.
Average
-58.10%
Median
-31.16%
Minimum
-489.14%
Maximum
164.71%
Discovering the peaks and valleys of BioAtla, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 199.24%
Maximum Annual ROE = 164.71%
Minimum Annual Increase = -133.67%
Minimum Annual ROE = -489.14%
| Year | ROE | Change |
|---|---|---|
| 2025 | 164.71% | -133.67% |
| 2024 | -489.14% | 179.99% |
| 2023 | -174.70% | 199.24% |
| 2022 | -58.38% | 29.01% |
| 2021 | -45.25% | 165.02% |
| 2020 | -17.07% | -132.07% |
| 2019 | 53.24% | -47.71% |
The current ROE of BioAtla, Inc. (BCAB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-166.38%
5-year avg
-120.55%
10-year avg
-58.10%
BioAtla, Inc.’s ROE is less than Celularity Inc. (411.46%), greater than PolyPid Ltd. (-241.96%), greater than Annovis Bio, Inc. (-318.08%), greater than Reviva Pharmaceuticals Holdings, Inc. (-220.39%), greater than Evaxion Biotech A/S (-77.79%), less than BioXcel Therapeutics, Inc. (75.79%), greater than Mural Oncology plc (-131.47%), greater than Generation Bio Co. (-94.82%), greater than Veru Inc. (-53.43%), less than Mersana Therapeutics, Inc. (183.15%),
| Company | ROE | Market cap |
|---|---|---|
| 411.46% | $18.10M | |
| -241.96% | $48.30M | |
| -318.08% | $34.43M | |
| -220.39% | $2.08M | |
| -77.79% | $19.27M | |
| 75.79% | $37.05M | |
| -131.47% | $35.38M | |
| -94.82% | $35.98M | |
| -53.43% | $47.35M | |
| 183.15% | $145.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioAtla, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioAtla, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioAtla, Inc.'s ROE?
How is the ROE calculated for BioAtla, Inc. (BCAB)?
What is the highest ROE for BioAtla, Inc. (BCAB)?
What is the 3-year average ROE for BioAtla, Inc. (BCAB)?
What is the 5-year average ROE for BioAtla, Inc. (BCAB)?
How does the current ROE for BioAtla, Inc. (BCAB) compare to its historical average?